Advertisement
Advertisement
CLDX
Celldex Therapeutics, Inc
29.87
USDSponsored
+1.60
+5.66%
Nov 06, 15:59 UTC -5
Closed
After-Market
30.05
+0.18
+0.60%
Celldex Therapeutics, Inc (CLDX)
Celldex Therapeutics, Inc Financial Snapshot
| Market Cap | 2.36B |
| Beta | 1.04 |
| Earnings Per Share (EPS) | -4.30 |
| Price-to-Book (P/B) Ratio | 3.19 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.17% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -52.35% |
| Current Ratio | 11.82% |
| Free Cash Flow | -127.82M |
